| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... Nature 483 (7391), 603-607, 2012 | 8236 | 2012 |
| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1451 | 2017 |
| Recurrent BRAF mutations in Langerhans cell histiocytosis G Badalian-Very, JA Vergilio, BA Degar, LE MacConaill, B Brandner, ... Blood, The Journal of the American Society of Hematology 116 (11), 1919-1923, 2010 | 1312 | 2010 |
| Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling N Wagle, C Emery, MF Berger, MJ Davis, A Sawyer, P Pochanard, ... Journal of clinical oncology 29 (22), 3085-3096, 2011 | 1220 | 2011 |
| High-throughput oncogene mutation profiling in human cancer RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ... Nature genetics 39 (3), 347-351, 2007 | 1175 | 2007 |
| MEK1 mutations confer resistance to MEK and B-RAF inhibition CM Emery, KG Vijayendran, MC Zipser, AM Sawyer, L Niu, JJ Kim, ... Proceedings of the National Academy of Sciences 106 (48), 20411-20416, 2009 | 790 | 2009 |
| Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations PK Brastianos, PM Horowitz, S Santagata, RT Jones, A McKenna, G Getz, ... Nature genetics 45 (3), 285-289, 2013 | 711 | 2013 |
| High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing N Wagle, MF Berger, MJ Davis, B Blumenstiel, M DeFelice, P Pochanard, ... Cancer discovery 2 (1), 82-93, 2012 | 651 | 2012 |
| Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway CA Lovejoy, W Li, S Reisenweber, S Thongthip, J Bruno, T De Lange, ... PLoS genetics 8 (7), e1002772, 2012 | 645 | 2012 |
| Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine EM Van Allen, N Wagle, P Stojanov, DL Perrin, K Cibulskis, S Marlow, ... Nature medicine 20 (6), 682-688, 2014 | 580 | 2014 |
| An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB J Min, A Zaslavsky, G Fedele, SK McLaughlin, EE Reczek, T De Raedt, ... Nature medicine 16 (3), 286-294, 2010 | 485 | 2010 |
| RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors PA Oberholzer, D Kee, P Dziunycz, A Sucker, N Kamsukom, R Jones, ... Journal of clinical oncology 30 (3), 316-321, 2012 | 471 | 2012 |
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC N Ahmadiyeh, MM Pomerantz, C Grisanzio, P Herman, L Jia, V Almendro, ... Proceedings of the National academy of sciences 107 (21), 9742-9746, 2010 | 451 | 2010 |
| Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer EP Garcia, A Minkovsky, Y Jia, MD Ducar, P Shivdasani, X Gong, ... Archives of Pathology and Laboratory Medicine 141 (6), 751-758, 2017 | 438 | 2017 |
| Institutional implementation of clinical tumor profiling on an unselected cancer population LM Sholl, K Do, P Shivdasani, E Cerami, AM Dubuc, FC Kuo, EP Garcia, ... JCI insight 1 (19), 2016 | 398 | 2016 |
| Profiling critical cancer gene mutations in clinical tumor samples LE MacConaill, CD Campbell, SM Kehoe, AJ Bass, C Hatton, L Niu, ... PloS one 4 (11), e7887, 2009 | 371 | 2009 |
| Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix AA Wright, BE Howitt, AP Myers, SE Dahlberg, E Palescandolo, ... Cancer 119 (21), 3776-3783, 2013 | 311 | 2013 |
| Clinical implications of the cancer genome LE MacConaill, LA Garraway Journal of Clinical Oncology 28 (35), 5219-5228, 2010 | 308 | 2010 |
| Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032 JN Søndergaard, R Nazarian, Q Wang, D Guo, T Hsueh, S Mok, ... Journal of translational medicine 8, 1-11, 2010 | 276 | 2010 |
| Frameshift events predict anti–PD-1/L1 response in head and neck cancer GJ Hanna, P Lizotte, M Cavanaugh, FC Kuo, P Shivdasani, A Frieden, ... JCI insight 3 (4), 2018 | 257 | 2018 |
